Step-by-step instructions for enrolling patients in the PMS Ally Patient Financial Assistance Program in Quebec
Enrolling your Quebec patients in the PMS Ally program is easy. Here are the step-by-step instructions. There are options to for card-only programs or programs that enroll patients into a patient support program. Drugs covered include Fingolimod, Abiraterone, Dimethyl Fumarate, Fampridine, Teriflunomide, Pazopanib, Apremilast and…
Amgen Entrust: patient registration and financial assistance program
Simple registration for your patients for the Amgen Entrust Patient Support Program. Generate a financial assistance card. No more physical cards or faxing required. Drugs covered include: Register your patients into the program now. Newsletter Sign-up
Welcome to the MyRx Elite™ patient registration and financial assistance program
For more information visit the MyRx™ Care portal. Newsletter Sign-up
The benefits of automating pharmacy practice
Technology has been playing an increasingly important role in the healthcare industry. For Canadian pharmacies, implementing new and improved technology can bring a wide range of benefits to help improve patient care, increase efficiency, and reduce costs. Here are a few key benefits of improving…
How to register your patients for the Ally financial assistance program
Instructions for Enrolling Patients into the PMS Ally Program through the MyRx Care portal. Drugs covered include: Fingolimod Abiraterone Dimethyl Fumarate Fampridine Teriflunomide Pazopanib Apremilast Tofacitinib Newsletter Sign-up
Patient education: insurance navigation and eligibility for financial assistance programs
For patients participating in a financial assistance program to cover medication costs in Canada, finding suitable insurance coverage can be a daunting task. Without insurance coverage, patients may face significant barriers in accessing financial assistance programs and may be unable to afford the medications they…
Canadian patients and biosimilars: A guide to talking to your pharmacist
The Ontario Drug Benefit (ODB) is expanding the use of biosimilars starting on March 31, 2023. This means that patients who were covered by certain biologics such as Humira® will have coverage switched to a biosimilar. This is a great time for patients to get…
The challenges in accessing and navigating Canadian financial assistance programs
Patient financial assistance programs for medications play a crucial role in ensuring access to essential treatments for individuals who are unable to afford their medication. However, the process of accessing and navigating these programs can be a complex and challenging experience for patients, which can…
Pharmacy practice: How pharmacists manage care for patients taking biosimilars
Pharmacists play a critical role in managing care for patients taking biosimilars. Biosimilars are a newer class of drugs that are designed to be similar to biologics, but they are not exact copies of the original biologic. They offer a more affordable option for patients…
Patient education: How Canadian pharmaceutical companies provide reimbursement programs for patients
In Canada, pharmaceutical companies play a crucial role in providing access to vital medications for patients. One way in which these companies support patients is through reimbursement programs. Reimbursement programs are designed to help patients cover the cost of their medications, ensuring that they receive…
